I personally believe that it might be higher than 6% market share. And this is a product that doesn't lend itself to the Byzentine pricing that the Big 4 use because DECN doesn't have to support manufacturing facilities. So a legacy-type product without legacy overhead. A perfect storm and an amazing back draft story behind the product.
(9)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links